Keep The Science In-House, Externalize The Hands

This segment of the Outsourced Pharma Live event, “ADC Outsourcing: Plan Smart Now Or Suffer Later,” explores what ADC sponsors should keep close even when relying heavily on external partners. Simon argues that sponsors should retain ownership of the science, including the critical quality attribute framework, reference standard strategy, specialized assays, and key analytical interpretation, while using CDMOs primarily for execution. Featuring Simon Letarte, Ph.D., Consultant, Biologics CMC Analytical Development, Oliyai Consulting Corporation.